SI0946550T1 - PREPARATION OF (1S-(1a,2b,3b,4a(S*)))-4-(7-((1-(3-CHLORO-2-THIENYL)METHYL)PROPYL)AMINO)-3H-IMIDAZO(4,5-b)PYRIDIN-3-yl)-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE - Google Patents

PREPARATION OF (1S-(1a,2b,3b,4a(S*)))-4-(7-((1-(3-CHLORO-2-THIENYL)METHYL)PROPYL)AMINO)-3H-IMIDAZO(4,5-b)PYRIDIN-3-yl)-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE

Info

Publication number
SI0946550T1
SI0946550T1 SI9730709T SI9730709T SI0946550T1 SI 0946550 T1 SI0946550 T1 SI 0946550T1 SI 9730709 T SI9730709 T SI 9730709T SI 9730709 T SI9730709 T SI 9730709T SI 0946550 T1 SI0946550 T1 SI 0946550T1
Authority
SI
Slovenia
Prior art keywords
dihydroxycyclopentanecarboxamide
imidazo
pyridin
thienyl
chloro
Prior art date
Application number
SI9730709T
Other languages
English (en)
Slovenian (sl)
Inventor
Michael K. O'brien
Herve Rhone-Poulenc Industrialisation GARCIA
Patrick Leon
Tory H. Powner
Laurence W. Reilly
Harshavadan C. Shah
Michael D. Thompson
Ching T. Tsuei
Benoit J. Vanasse
Francis L. Walther
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of SI0946550T1 publication Critical patent/SI0946550T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
SI9730709T 1996-12-11 1997-11-24 PREPARATION OF (1S-(1a,2b,3b,4a(S*)))-4-(7-((1-(3-CHLORO-2-THIENYL)METHYL)PROPYL)AMINO)-3H-IMIDAZO(4,5-b)PYRIDIN-3-yl)-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE SI0946550T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3276496P 1996-12-11 1996-12-11
EP97950663A EP0946550B1 (en) 1996-12-11 1997-11-24 PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL)METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
PCT/US1997/021439 WO1998025921A1 (en) 1996-12-11 1997-11-24 PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE

Publications (1)

Publication Number Publication Date
SI0946550T1 true SI0946550T1 (en) 2005-10-31

Family

ID=21866680

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730709T SI0946550T1 (en) 1996-12-11 1997-11-24 PREPARATION OF (1S-(1a,2b,3b,4a(S*)))-4-(7-((1-(3-CHLORO-2-THIENYL)METHYL)PROPYL)AMINO)-3H-IMIDAZO(4,5-b)PYRIDIN-3-yl)-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE

Country Status (27)

Country Link
US (2) US6143894A (es)
EP (2) EP1609791A1 (es)
JP (1) JP2001506626A (es)
KR (4) KR100510389B1 (es)
CN (3) CN1191251C (es)
AP (1) AP1063A (es)
AT (1) ATE301120T1 (es)
AU (1) AU738581B2 (es)
BG (1) BG63805B1 (es)
BR (1) BR9713705A (es)
CA (1) CA2274630C (es)
DE (1) DE69733897T2 (es)
DK (1) DK0946550T3 (es)
EA (1) EA001989B1 (es)
ES (1) ES2242984T3 (es)
HK (2) HK1023998A1 (es)
HU (1) HUP0000342A3 (es)
IL (1) IL130397A (es)
MX (1) MXPA03006730A (es)
NO (2) NO319722B1 (es)
OA (1) OA11061A (es)
PT (1) PT946550E (es)
SI (1) SI0946550T1 (es)
SK (1) SK71199A3 (es)
UA (1) UA54479C2 (es)
WO (1) WO1998025921A1 (es)
ZA (1) ZA9711035B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1140933T1 (en) 1998-12-31 2005-02-28 Aventis Pharmaceuticals Inc. Process for preparing n6-substituted deaza-adenosine derivatives
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
FR2846656B1 (fr) * 2002-11-05 2004-12-24 Servier Lab Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2505085B2 (ja) * 1990-09-25 1996-06-05 ローヌ−プーラン ローラー インターナショナル （ホウルディングス） インコーポレイテッド 抗昇圧および抗虚血特性を有する化合物
AU746706B2 (en) * 1997-07-03 2002-05-02 Du Pont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
EA003645B1 (ru) * 1998-12-21 2003-08-28 Авентис Фармасьютикалз Инк. Способ получения n6-замещенных производных деаза-аденозина

Also Published As

Publication number Publication date
NO20052327L (no) 1999-08-10
CN1090630C (zh) 2002-09-11
AP1063A (en) 2002-04-26
PT946550E (pt) 2005-09-30
HK1023998A1 (en) 2000-09-29
DK0946550T3 (da) 2005-08-29
MXPA03006730A (es) 2003-10-24
US6143894A (en) 2000-11-07
KR20050046793A (ko) 2005-05-18
UA54479C2 (uk) 2003-03-17
WO1998025921A1 (en) 1998-06-18
IL130397A (en) 2005-11-20
BR9713705A (pt) 2000-05-09
NO319722B1 (no) 2005-09-05
BG63805B1 (bg) 2003-01-31
EP0946550A4 (en) 2003-05-14
DE69733897T2 (de) 2006-06-01
AU5360798A (en) 1998-07-03
KR20060002030A (ko) 2006-01-06
EP0946550A1 (en) 1999-10-06
OA11061A (en) 2002-02-27
BG103484A (en) 2000-06-30
NO992795L (no) 1999-08-10
KR20000057505A (ko) 2000-09-15
IL130397A0 (en) 2000-06-01
CN1394859A (zh) 2003-02-05
NO992795D0 (no) 1999-06-09
EA001989B1 (ru) 2001-10-22
CA2274630C (en) 2000-10-03
CN1240445A (zh) 2000-01-05
SK71199A3 (en) 2000-07-11
EA199900527A1 (ru) 2000-02-28
CN1191251C (zh) 2005-03-02
HUP0000342A3 (en) 2001-01-29
ATE301120T1 (de) 2005-08-15
AP9901550A0 (en) 1999-06-30
KR100571690B1 (ko) 2006-04-18
AU738581B2 (en) 2001-09-20
NO20052327D0 (no) 2005-05-12
KR100510389B1 (ko) 2005-08-31
KR20060002029A (ko) 2006-01-06
ES2242984T3 (es) 2005-11-16
JP2001506626A (ja) 2001-05-22
US6235909B1 (en) 2001-05-22
ZA9711035B (en) 1998-06-15
CN1660842A (zh) 2005-08-31
DE69733897D1 (de) 2005-09-08
EP0946550B1 (en) 2005-08-03
HUP0000342A2 (hu) 2000-10-28
EP1609791A1 (en) 2005-12-28
HK1051862A1 (en) 2003-08-22

Similar Documents

Publication Publication Date Title
SI1001955T1 (en) 1,2,4-triazolo 4,3-b)pyrido 3,2-d)pyridazine derivatives and pharmaceutical compositions containing them
HUP0001805A3 (en) 6-benzyl-1,5-dihydro-pyrazolo[3,4-d]-pyrimidin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
IL110286A0 (en) Pyrido(2,3-d) pyridazin-5-one and pyrido(2,3-d)pyridazin-5-thione derivatives, processes for their preparation and herbicidal compositions containing them
HUP0202494A2 (en) Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
EP1043998A4 (en) USE OF PYRAZOLO 3,4-b] PYRIDINE AS CYCLINE DEPENDENT KINASE INHIBITORS
HUP0001507A3 (en) Pyrrolo [2,3-d] pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0000720A3 (en) Imidazo [1,2-a] pyridine derivatives, process for their preparation, pharmaceutical formulation containing them and their use
NZ286256A (en) (hetero) arylalkylsubstituted naphthyridine and pyrido fused oxazacyclic derivatives
HUP0100179A3 (en) Imidazopyrimidine and imidazopyridine derivatives and pharmaceutical compositions thereof
HUP0203450A3 (en) Pyrazolo '4,3-d! pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them and their use
IL129502A0 (en) Naphthyridine derivatives
IL123036A0 (en) 8-substituted-1,3,8-triaza-spiro Ú4,5¾ decan-4-on derivatives their preparation and pharmaceutical compositions containing them
HUP9802940A3 (en) Quinoline-2(1h)-one derivatives as serotonin antagonists, preparation and use thereof
AU2404897A (en) Fused imidazopyridine derivatives as antihyperlipidemic agents
IL122642A0 (en) Substituted purine derivatives processes for their preparation their use and compositions comprising them
HUP0003826A3 (en) Novel triazolo [4,5-b] pyrimidine derivatives, process for their preparation and pharmaceutical compositions thereof
IL117824A0 (en) Use of imidazo [1,2-alpha] pyridine-3-acetamide derivatives
AU2002361407A1 (en) Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
HRP970484A2 (en) 3-substituted pyrido /4',3':4,5/thieno/2,3-d/pyrimidine derivatives, their preparation and their use
PL349364A1 (en) Use of pyridazino[4,5-b
HUP0105054A3 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation
SI0946550T1 (en) PREPARATION OF (1S-(1a,2b,3b,4a(S*)))-4-(7-((1-(3-CHLORO-2-THIENYL)METHYL)PROPYL)AMINO)-3H-IMIDAZO(4,5-b)PYRIDIN-3-yl)-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
HUP0002736A3 (en) 3-substituted pyrido [3',4':4,5]thieno[2,3-d]pyrimidine derivatives, and their use for the preparation of pharmaceutical compositions
IL133512A0 (en) 5-substituted -3- oxadiazolyl - 1, 6-naphthyridin - 2 (1h) - one derivatives